Literature DB >> 17622233

Is single-agent temozolomide the treatment of choice for recurrent primary central nervous system lymphoma?

Antonio M P Omuro1.   

Abstract

Entities:  

Year:  2007        PMID: 17622233     DOI: 10.1038/ncponc0898

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN: 1743-4254


× No keyword cloud information.
  1 in total

1.  Treatment and prophylaxis of hematologic malignancy in the central nervous system.

Authors:  Seema Nagpal; Lawrence Recht
Journal:  Curr Treat Options Neurol       Date:  2011-08       Impact factor: 3.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.